Health In Tech director may sell 12,000 shares

Director Timothy Hayes has filed a Rule 144 notice covering a potential sale of 12,000 HIT common shares, following recent sales totaling 17,730 shares.

Rhea-AI Filing Summary

Health In Tech, Inc. (HIT) filed a notice that director Timothy Hayes may sell up to 12,000 shares of the company’s common stock, to be sold through Apex Clearing on the Nasdaq Stock Market, with an aggregate market value of $10,776.00 as of September 14, 2026. The shares relate to a Restricted Stock Award that vested on June 23, 2025. The notice also reports prior sales by Hayes over the past three months totaling 5,730 shares for $5,352.81 on September 9, 2026 and 12,000 shares for $11,010.59 on September 11, 2026.

Key Figures

Shares covered by Form 144: 12,000 shares Aggregate market value of shares to be sold: $10,776.00 Sale on September 9, 2026: 5,730 shares for $5,352.81 +2 more

5 metrics

Shares covered by Form 144 12,000 shares Common stock of Health In Tech, Inc. to be sold through Apex Clearing

Aggregate market value of shares to be sold $10,776.00 Value of 12,000 HIT common shares as of September 14, 2026

Sale on September 9, 2026 5,730 shares for $5,352.81 HIT common stock sold by Timothy Hayes during prior 3 months

Sale on September 11, 2026 12,000 shares for $11,010.59 HIT common stock sold by Timothy Hayes during prior 3 months

Restricted Stock Award vesting date June 23, 2025 Source of the 12,000 common shares covered by the notice

Key Terms

Rule 144, Restricted Stock Award Vesting, Nasdaq Stock Market

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Award Vesting financial

"Common | 06/23/2025 | Restricted Stock Award Vesting | Health In Tech, Inc."

Nasdaq Stock Market market

"53834658 | 09/14/2026 | Nasdaq Stock Market"

The Nasdaq Stock Market is a place where many companies' shares are bought and sold, functioning like a marketplace for investing in businesses. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping people grow their wealth or fund business growth. Known for hosting many technology and innovative companies, it is a key indicator of the health of those sectors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Health In Tech, Inc. (HIT) disclose in this Form 144 filing?

The filing reports that director Timothy Hayes has filed a Rule 144 notice covering a potential sale of 12,000 shares of HIT common stock, linked to a Restricted Stock Award vesting on June 23, 2025, and lists related sales in the prior three months.

How many Health In Tech (HIT) shares may Timothy Hayes sell under this Form 144?

The notice covers a potential sale of 12,000 shares of HIT common stock. These shares are to be sold through Apex Clearing on the Nasdaq Stock Market, with an aggregate market value of $10,776.00 as of September 14, 2026.

What recent HIT share sales by Timothy Hayes are reported in the Form 144?

The document lists two recent sales: 5,730 shares of HIT common stock for $5,352.81 on September 9, 2026, and 12,000 shares for $11,010.59 on September 11, 2026.

What type of Health In Tech (HIT) securities are involved in Timothy Hayes’ Form 144?

The securities are common stock of Health In Tech, Inc., associated with a Restricted Stock Award Vesting dated June 23, 2025. The notice and recent transactions all relate to this class of common stock.

On which market are Timothy Hayes’ HIT shares expected to be sold?

The notice states that the 12,000 shares covered by the Form 144 are to be sold through Apex Clearing on the Nasdaq Stock Market, with an aggregate market value of $10,776.00 as of September 14, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:44 PM Accepted by SEC EDGAR 09/14/2026 - 04:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002020283
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health In Tech, Inc.
SEC File Number	001-42449
Address of Issuer	701 S. Colorado Ave Suite 1 Stuart FLORIDA 34994
Phone	8883730333
Name of Person for Whose Account the Securities are To Be Sold	Hayes Timothy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	DIRECTOR

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	APEX CLEARING 350 N ST. PAUL ST SUITE 300 DALLAS TX 75201	12000	10776.00	53834658	09/14/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/23/2025	Restricted Stock Award Vesting	Health In Tech, Inc.			12000	06/23/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Timothy Hayes 701 S. Colorado Ave Suite 1 Stuart FL 34994	Common	09/09/2026	5730	5352.81
Timothy Hayes 701 S. Colorado Ave Suite 1 Stuart FL 34994	Common	09/11/2026	12000	11010.59

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Timothy Hayes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)